A share price of Opus Genetics Inc [IRD] is currently trading at $2.1, up 0.96%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IRD shares have gain 8.81% over the last week, with a monthly amount drifted -1.87%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Opus Genetics Inc [NASDAQ: IRD] stock has seen the most recent analyst activity on December 10, 2025, when B. Riley Securities initiated its Buy rating and assigned the stock a price target of $9. Previously, Piper Sandler started tracking the stock with Overweight rating on November 25, 2025, and set its price target to $7. On October 29, 2025, Wedbush initiated with a Outperform rating and assigned a price target of $8 on the stock. Chardan Capital Markets started tracking the stock assigning a Buy rating and suggested a price target of $9 on October 16, 2025. Craig Hallum initiated its recommendation with a Buy and recommended $6 as its price target on April 11, 2025.
Opus Genetics Inc experienced fluctuations in its stock price throughout the past year between $0.65 and $2.59. Currently, Wall Street analysts expect the stock to reach $7 within the next 12 months. Opus Genetics Inc [NASDAQ: IRD] shares were valued at $2.1 at the most recent close of the market. An investor can expect a potential return of 233.33% based on the average IRD price forecast.
Analyzing the IRD fundamentals
Trailing Twelve Months sales for Opus Genetics Inc [NASDAQ:IRD] were 14.63M which represents -20.38% decline. Gross Profit Margin for this corporation currently stands at 0.06% with Operating Profit Margin at -4.45%, Pretax Profit Margin comes in at -4.66%, and Net Profit Margin reading is -4.66%. To continue investigating profitability, this company’s Return on Assets is posted at -1.89, Equity is -7.74 and Total Capital is -9.26. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Opus Genetics Inc [NASDAQ:IRD] is 1.23. In addition, the Quick Ratio stands at 1.23 and the Cash Ratio stands at 1.06. Considering the valuation of this stock, the price to sales ratio is 9.90, the price to book ratio is 22.71.
Transactions by insiders
Recent insider trading involved Gallagher Cam, Director, that happened on Dec 29 ’25 when 83000.0 shares were purchased. Director, Gallagher Cam completed a deal on Dec 29 ’25 to buy 81000.0 shares. Meanwhile, Director Foundation Fighting Blindness sold 4.0 million shares on Dec 09 ’25.
